Novasep, a leading global manufacturing solutions provider for fine chemicals, has appointed Michel Spagnol as chairman of the Supervisory Board of the company after the founder of the group, Roger-Marc Nicoud left the company.
Michel Spagnol joined Novasep as CEO in June 2013. Since then, he has reinforced the executive management team with the appointments of Christian Thiry as chief financial officer, Thierry Van Nieuwenhove as president of the Synthesis Business Unit and the promotion of Nadege Laborde as president of the Industrial Biotech Unit.
Michel Spagnol also engaged the company in a number of strategic orientations, encompassing commercial, operational, human and innovation excellence, aimed at focusing on customer satisfaction. Novasep has achieved significant milestones for its key development projects, such as the completion of the world’s largest chromatographic plant for the purification of omega-3s at its Mourenx facility, France, and the successful validation of its ADC payload commercial production workshops at its Le Mans facility, France. In the last nine months, these facilities and the Leverkusen site in Germany received successful FDA inspections, demonstrating Novasep’s continued commitment to quality.
Novasep offers process development services, purification equipment and turnkey processes, contract manufacturing services and complex active molecules to serve pharmaceutical, biopharmaceutical, fine chemical, food and functional ingredients industries.